|

PeptiCRAd-1 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Valo Therapeutics Oy1

Indications

  • Myxoid Liposarcoma1
  • Synovial Sarcoma1
  • Melanoma (Skin)1
  • Sarcoma1
  • Osteosarcoma1

Other1 trial

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.